Fecal microbiota analysis of polycystic kidney disease patients according to renal function: A pilot study
暂无分享,去创建一个
G. Nadkarni | J. Uribarri | J. He | D. McSkimming | R. Yacoub | L. Chaves | Sham Abyad | Mark A Bryniarski | Amanda Honan | Shruthi Thomas | M. Gowda | Rabi Yacoub
[1] R. Genco,et al. Chronic kidney disease, uremic milieu, and its effects on gut bacterial microbiota dysbiosis. , 2018, American journal of physiology. Renal physiology.
[2] Guixia Wang,et al. The Relationship between Frequently Used Glucose-Lowering Agents and Gut Microbiota in Type 2 Diabetes Mellitus , 2018, Journal of diabetes research.
[3] Michael Y. Gerner,et al. Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism , 2018, Nature.
[4] M. Veldhoen,et al. Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases , 2018, Nature Communications.
[5] T. Nickolas,et al. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[6] Rabi Yacoub,et al. Lupus: The microbiome angle. , 2017, Immunobiology.
[7] Wei Zheng,et al. Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial , 2017, PloS one.
[8] Mary B Leonard,et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. , 2017, Kidney international.
[9] Y. Fujioka,et al. Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis? , 2017, Journal of atherosclerosis and thrombosis.
[10] Hong-Wei Zhou,et al. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients , 2017, Scientific Reports.
[11] J. Adamski,et al. Metabolomics for clinical use and research in chronic kidney disease , 2017, Nature Reviews Nephrology.
[12] G. Parati,et al. The systemic nature of CKD , 2017, Nature Reviews Nephrology.
[13] William Tottey,et al. Colonic Transit Time Is a Driven Force of the Gut Microbiota Composition and Metabolism: In Vitro Evidence , 2017, Journal of neurogastroenterology and motility.
[14] T. R. Licht,et al. Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut , 2016, Nature Microbiology.
[15] Vinícius Andrade-Oliveira,et al. The microbiota and chronic kidney diseases: a double-edged sword , 2016, Clinical & translational immunology.
[16] T. Preston,et al. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism , 2016, Gut microbes.
[17] Judith Aron-Wisnewsky,et al. The gut microbiome, diet, and links to cardiometabolic and chronic disorders , 2016, Nature Reviews Nephrology.
[18] M. Kanehisa,et al. BlastKOALA and GhostKOALA: KEGG Tools for Functional Characterization of Genome and Metagenome Sequences. , 2016, Journal of molecular biology.
[19] R. Follador,et al. Iron Modulates Butyrate Production by a Child Gut Microbiota In Vitro , 2015, mBio.
[20] D. Fouque,et al. Trimethylamine N-Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet. , 2015, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[21] Minoru Kanehisa,et al. KEGG as a reference resource for gene and protein annotation , 2015, Nucleic Acids Res..
[22] Jens Roat Kultima,et al. Disentangling the effects of type 2 diabetes and metformin on the human gut microbiota , 2016 .
[23] P. Jose,et al. Gut microbiota in hypertension , 2015, Current opinion in nephrology and hypertension.
[24] V. Jala,et al. Evidence for a link between gut microbiota and hypertension in the Dahl rat. , 2015, Physiological genomics.
[25] C. Pepine,et al. Gut Dysbiosis Is Linked to Hypertension , 2015, Hypertension.
[26] S. Peterson,et al. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota , 2015, Clinical and experimental immunology.
[27] K. Maloy,et al. Modulation of immune development and function by intestinal microbiota. , 2014, Trends in immunology.
[28] S. Hazen,et al. The contributory role of gut microbiota in cardiovascular disease. , 2014, The Journal of clinical investigation.
[29] Estela Trebicka,et al. Intestinal Inflammation Modulates Expression of the Iron-Regulating Hormone Hepcidin Depending on Erythropoietic Activity and the Commensal Microbiota , 2014, The Journal of Immunology.
[30] L. Gesualdo,et al. What Would You Like to Eat, Mr CKD Microbiota? A Mediterranean Diet, please! , 2014, Kidney and Blood Pressure Research.
[31] H. Tilg,et al. Microbiota and diabetes: an evolving relationship , 2014, Gut.
[32] Maurice Kriegel,et al. Diet, microbiota and autoimmune diseases , 2014, Lupus.
[33] Y. Belkaid,et al. Role of the Microbiota in Immunity and Inflammation , 2014, Cell.
[34] S. Rampelli,et al. Inflammation and colorectal cancer, when microbiota-host mutualism breaks. , 2014, World journal of gastroenterology.
[35] Jiajie Zhang,et al. PEAR: a fast and accurate Illumina Paired-End reAd mergeR , 2013, Bioinform..
[36] Jesse R. Zaneveld,et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences , 2013, Nature Biotechnology.
[37] S. Hazen,et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. , 2013, The New England journal of medicine.
[38] F. Bushman,et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis , 2013, Nature Medicine.
[39] G. Andersen,et al. Chronic kidney disease alters intestinal microbial flora. , 2013, Kidney international.
[40] Keith C. Norris,et al. Role of Urea in Intestinal Barrier Dysfunction and Disruption of Epithelial Tight Junction in Chronic Kidney Disease , 2012, American Journal of Nephrology.
[41] Michael A Kennedy,et al. Quantification and statistical significance analysis of group separation in NMR-based metabonomics studies. , 2011, Chemometrics and intelligent laboratory systems : an international journal sponsored by the Chemometrics Society.
[42] G. Macfarlane,et al. Fermentation in the Human Large Intestine: Its Physiologic Consequences and the Potential Contribution of Prebiotics , 2011, Journal of clinical gastroenterology.
[43] Jacques Amar,et al. Gut microbiota and diabetes: from pathogenesis to therapeutic perspective , 2011, Acta Diabetologica.
[44] Gaël Varoquaux,et al. The NumPy Array: A Structure for Efficient Numerical Computation , 2011, Computing in Science & Engineering.
[45] Gaël Varoquaux,et al. Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..
[46] K. Verbeke,et al. p-Cresol and cardiovascular risk in mild-to-moderate kidney disease. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[47] R. Pincus,et al. Aitchison, J.: The Statistical Analysis of Compositional Data. Chapman and Hall, London ‐ New York 1986, XII, 416 pp., £ 25,00 , 2007 .
[48] Tom Greene,et al. Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.
[49] K. Verbeke,et al. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. , 2006, Kidney international.
[50] Eoin L. Brodie,et al. Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB , 2006, Applied and Environmental Microbiology.
[51] J. Bailey. Metabolic acidosis: an unrecognized cause of morbidity in the patient with chronic kidney disease. , 2005, Kidney international. Supplement.
[52] K. Kalantar-Zadeh,et al. Risks of chronic metabolic acidosis in patients with chronic kidney disease. , 2005, Kidney international. Supplement.
[53] J. Kraut,et al. Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[54] Xiaonan H. Wang,et al. Acidosis impairs insulin receptor substrate-1-associated phosphoinositide 3-kinase signaling in muscle cells: consequences on proteolysis. , 2004, American journal of physiology. Renal physiology.
[55] Chi-Sen Chang,et al. Colonic transit time in long-term dialysis patients. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[56] M. Fine,et al. Development of a symptom assessment instrument for chronic hemodialysis patients: the Dialysis Symptom Index. , 2004, Journal of pain and symptom management.
[57] K. Verbeke,et al. Evidence for impaired assimilation of protein in chronic renal failure. , 2003, Kidney international.
[58] H. Takanaga,et al. Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney. , 2002, Kidney international.
[59] P. Toutain,et al. Small bowel motility and colonic transit are altered in dogs with moderate renal failure. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.
[60] F. Santos,et al. Resistance to growth hormone and insulin-like growth factor-I in acidotic rats , 2000, Pediatric Nephrology.
[61] R. Vanholder,et al. p-cresol and uric acid: two old uremic toxins revisited. , 1997, Kidney international. Supplement.
[62] E. Quintero,et al. Gastrin mediates the increase in gastric cell growth in uremic rats. , 1995, The American journal of physiology.
[63] N. Vaziri,et al. Enhanced enteric excretion of urate in rats with chronic renal failure. , 1994, Clinical science.
[64] R. Vanholder,et al. Uremic toxicity: the middle molecule hypothesis revisited. , 1994, Seminars in nephrology.
[65] J. Y. Kang,et al. The gastrointestinal tract in uremia , 1993, Digestive diseases and sciences.
[66] R. De Giorgio,et al. Uremia increases gastric mucosal permeability and acid back-diffusion injury in the rat. , 1992, Gastroenterology.
[67] J. Cummings,et al. Effect of changing transit time on colonic microbial metabolism in man. , 1987, Gut.
[68] John Aitchison,et al. The Statistical Analysis of Compositional Data , 1986 .
[69] R. Miller,et al. Pathology of gastrointestinal tract in chronic hemodialysis patients: an autopsy study of 78 cases. , 1985, The American journal of gastroenterology.
[70] J. Cummings,et al. The effect of meat protein and dietary fiber on colonic function and metabolism. I. Changes in bowel habit, bile acid excretion, and calcium absorption. , 1979, The American journal of clinical nutrition.
[71] B. Widmer,et al. Serum electrolyte and acid base composition. The influence of graded degrees of chronic renal failure. , 1979, Archives of internal medicine.
[72] J. Cummings,et al. The effect of meat protein and dietary fiber on colonic function and metabolism. II. Bacterial metabolites in feces and urine. , 1979, The American journal of clinical nutrition.
[73] Y. Sanz,et al. Microbiota, inflammation and obesity. , 2014, Advances in experimental medicine and biology.
[74] Jens Roat Kultima,et al. Disentangling the effects of type 2 diabetes and metformin on the human gut microbiota , 2015, Nature.
[75] Wes McKinney,et al. Data Structures for Statistical Computing in Python , 2010, SciPy.
[76] Matthew Novak,et al. Improvement in Pittsburgh Symptom Score index after initiation of peritoneal dialysis. , 2008, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.
[77] J. Bernardini,et al. The relationship between symptoms, depression, and quality of life in peritoneal dialysis patients. , 2006, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.
[78] Eric Jones,et al. SciPy: Open Source Scientific Tools for Python , 2001 .
[79] Fred L. Drake,et al. The Python Language Reference Manual , 1999 .
[80] P. Kes. Serum gastrin concentration in chronic renal failure. , 1992, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti.
[81] D. Warnock. Uremic acidosis. , 1988, Kidney international.
[82] S. Shen,et al. The statistical analysis of compositional data , 1983 .
[83] Y. Lee,et al. Urea concentration in intestinal fluids in normal and uremic dogs , 1971, Journal of surgical oncology.